Loading organizations...
Loading organizations...
Biotechnology company developing immune tolerance therapies for diseases.
Topas Therapeutics has raised $62.8M across 3 funding rounds.
Topas Therapeutics has raised $62.8M in total across 3 funding rounds.
Topas Therapeutics has raised $62.8M in total across 3 funding rounds.
Topas Therapeutics's investors include BioMedPartners, Boehringer Ingelheim, EMBL Ventures, Epidarex Capital, Werner Lanthaler, Gimv, Vesalius Biocapital, Michael Wacker, Marc Lohrmann, Evotec.
Topas Therapeutics has raised $62.8M across 3 funding rounds. Most recently, it raised $21.3M Series B Extension in July 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 29, 2021 | $21.3M Series B Extension | BioMedPartners, Boehringer Ingelheim, EMBL Ventures, Epidarex Capital, Werner Lanthaler, Gimv, Vesalius Biocapital | |
| Oct 19, 2020 | $25.9M Series B | Michael Wacker, Marc Lohrmann | |
| Mar 23, 2016 | $15.6M Series A | Epidarex Capital | EMBL Ventures, Evotec, Gimv |